Back to search

Article

Improved Intrvenous Lentiviral Gene Therapy Based on Endothelial-specific Factor VIII for Hemophilia A

2023-03-13

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Hemophilia A (HA) is an X-linked monogenic disorder caused by deficiency of the factor VIII (FVIII, F8) gene in the intrinsic coagulation cascade. The current protein replacement therapy (PRT) of HA has many limitations including short term effectiveness, high cost, and life-time treatment requirement. Gene therapy has become a promising treatment for HA. Orthot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d55332de-413a-54de-87f7-f73da5a17dfb
DOI
10.21203/rs.3.rs-2637226/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Improved Intrvenous Lentiviral Gene Therapy Based on Endothelial-specific Factor VIII for Hemophilia ADOI 10.21203/rs.3.rs-2637226/v1
Select a neighboring publication to make it the new centre.